1-6 of 6
Stephen J. Nicholls
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

Gregory G. Schwartz, Lawrence A. Leiter, Christie M. Ballantyne, Philip J. Barter, Donald M. Black, David Kallend, Fouzia Laghrissi-Thode, Eran Leitersdorf, John J.V. McMurray, Stephen J. Nicholls, Anders G. Olsson, David Preiss, Prediman K. Shah, Jean-Claude Tardif, John Kittelson
Journal: Diabetes Care
Diabetes Care 2020;43(5):1077–1084
https://doi.org/10.2337/dc19-2204
Published: 06 March 2020
View article titled, Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
Open the PDF for Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease in another window
Includes: Supplementary data
Journal Articles

The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE

Nishant P. Shah, Qiuqing Wang, Katherine E. Wolski, Leslie Cho, Ellen McErlean, Giacomo Ruotolo, Govinda Weerakkody, Jeffrey S. Riesmeyer, Stephen J. Nicholls, A. Michael Lincoff, Steven E. Nissen, Venu Menon
Journal: Diabetes Care
Diabetes Care 2020;43(2):e22–e24
https://doi.org/10.2337/dc19-1117
Published: 05 December 2019
View article titled, The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE
Open the PDF for The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE in another window
Journal Articles

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial

Venu Menon, A. Michael Lincoff, Stephen J. Nicholls, Susan Jasper, Kathy Wolski, Darren K. McGuire, Cyrus R. Mehta, Julio Rosenstock, Claudia Lopez, John Marcinak, Charlie Cao, Steven E. Nissen
Journal: Diabetes Care
Diabetes Care 2018;41(12):2603–2609
https://doi.org/10.2337/dc18-0755
Published: 12 November 2018
View article titled, Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial
Open the PDF for Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial in another window
Includes: Supplementary data
Journal Articles

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Ilse C. Schrieks, Anna Nozza, Barbara E. Stähli, John B. Buse, Robert R. Henry, Klas Malmberg, Bruce Neal, Stephen J. Nicholls, Lars Rydén, Linda Mellbin, Anders Svensson, Hans Wedel, Arlette Weichert, A. Michael Lincoff, Jean-Claude Tardif, Diederick E. Grobbee, Gregory G. Schwartz
Journal: Diabetes Care
Diabetes Care 2018;41(8):1792–1800
https://doi.org/10.2337/dc18-0158
Published: 14 June 2018
View article titled, Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome
Open the PDF for Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome in another window
Includes: Supplementary data
Journal Articles

Response to Comment on Stegman et al. High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN. Diabetes Care 2014;37:3114–3120

Brian Stegman, Rishi Puri, Mingyuan Shao, Stephen J. Nicholls
Journal: Diabetes Care
Diabetes Care 2015;38(2):e28–e29
https://doi.org/10.2337/dc14-2552
Published: 10 January 2015
View article titled, Response to Comment on Stegman et al. High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN. Diabetes Care 2014;37:3114–3120
Open the PDF for Response to Comment on Stegman et al. High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN. Diabetes Care 2014;37:3114–3120 in another window
Journal Articles

High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN

Brian Stegman, Rishi Puri, Leslie Cho, Mingyuan Shao, Christie M. Ballantyne, Phillip J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka, Steven E. Nissen, Stephen J. Nicholls
Journal: Diabetes Care
Diabetes Care 2014;37(11):3114–3120
https://doi.org/10.2337/dc14-1121
Published: 10 October 2014
View article titled, High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN
Open the PDF for High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN in another window
Includes: Supplementary data